Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1 Wearing down a diagnosis
- Case 2 The woman who couldn’t handle her lips smacking any longer
- Case 3 The depressed bipolar patient on multiple medications
- Case 4 The agitated patient who finally wasn’t
- Case 5 The George who was not psychotic but anxious and distracted
- Case 6 The man who saw enemies everywhere
- Case 7 The young woman with psychosis complicated by substance use and a history of traumatic brain injury
- Case 8 The woman with worsening psychosis and a mysterious rash
- Case 9 The man without a plan
- Case 10 The anxious depressed woman who couldn’t sit still
- Case 11 The man who thinks it’s the end of the world
- Case 12 Sunny with a chance of depression
- Case 13 A not-so-simple case of anxiety
- Case 14 I’m a woman in a man’s body
- Case 15 The spacey, fidgety son with overwhelming sadness
- Case 16 The man who spent thousands online
- Case 17 The traumatized mother who can’t stop bingeing
- Case 18 The man who couldn’t stop hitting people
- Case 19 Brexpiprazole: “an awakening”
- Case 20 Treatment-resistant depression and opioid dependence
- Case 21 A stiff patient
- Case 22 An adolescent awakening
- Case 23 The peace keeper with a left breast mass
- Case 24 The girl who slept with problems
- Case 25 Not all child’s play: a path to pediatric stability
- Case 26 The young woman who was “nothing but skin and bones”
- Case 27 Could it be both? Comorbid psychiatric diagnoses
- Case 28 Treatment-emergent mania/hypomania in a depressed patient
- Case 29 The border between mood and personality
- Case 30 The student who wanted to go to rehab
- Case 31 The boy who wouldn’t (couldn’t) listen
- Case 32 The patient who went streaking
- Case 33 “Perseverance”
- Case 34 Clozapine (Clozaril) candidate discombobulates compassionate clinicians
- Index of drug names
- Index of case studies
- References
Case 26 - The young woman who was “nothing but skin and bones”
Published online by Cambridge University Press: 19 October 2021
Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1 Wearing down a diagnosis
- Case 2 The woman who couldn’t handle her lips smacking any longer
- Case 3 The depressed bipolar patient on multiple medications
- Case 4 The agitated patient who finally wasn’t
- Case 5 The George who was not psychotic but anxious and distracted
- Case 6 The man who saw enemies everywhere
- Case 7 The young woman with psychosis complicated by substance use and a history of traumatic brain injury
- Case 8 The woman with worsening psychosis and a mysterious rash
- Case 9 The man without a plan
- Case 10 The anxious depressed woman who couldn’t sit still
- Case 11 The man who thinks it’s the end of the world
- Case 12 Sunny with a chance of depression
- Case 13 A not-so-simple case of anxiety
- Case 14 I’m a woman in a man’s body
- Case 15 The spacey, fidgety son with overwhelming sadness
- Case 16 The man who spent thousands online
- Case 17 The traumatized mother who can’t stop bingeing
- Case 18 The man who couldn’t stop hitting people
- Case 19 Brexpiprazole: “an awakening”
- Case 20 Treatment-resistant depression and opioid dependence
- Case 21 A stiff patient
- Case 22 An adolescent awakening
- Case 23 The peace keeper with a left breast mass
- Case 24 The girl who slept with problems
- Case 25 Not all child’s play: a path to pediatric stability
- Case 26 The young woman who was “nothing but skin and bones”
- Case 27 Could it be both? Comorbid psychiatric diagnoses
- Case 28 Treatment-emergent mania/hypomania in a depressed patient
- Case 29 The border between mood and personality
- Case 30 The student who wanted to go to rehab
- Case 31 The boy who wouldn’t (couldn’t) listen
- Case 32 The patient who went streaking
- Case 33 “Perseverance”
- Case 34 Clozapine (Clozaril) candidate discombobulates compassionate clinicians
- Index of drug names
- Index of case studies
- References
Summary
Pretest self-assessment question (answer at the end of the case)
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential Psychopharmacology , pp. 307 - 324Publisher: Cambridge University PressPrint publication year: 2021
References
American Psychiatric Association. (2013). Eating and feeding disorders. In: Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Arlington, VA: American Psychiatric Association, 2013. Available from: https://doi.org/10.1176/appi.books.9780890425596.dsm10Google Scholar
Arcelus, J, Mitchell, AJ, Wales, J, Nielsen, S. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry 2011; 68:724–31. https://doi.org/10.1001/archgenpsychiatry.2011.74CrossRefGoogle ScholarPubMed
Attia, E, Steinglass, JE, Walsh, BT, et al. Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial. Am J Psychiatry 2019; 176:449–56. https://doi.org/10.1176/appi.ajp.2018.18101125Google Scholar
Baker, JH, Schaumberg, K, Munn-Chernoff, MA. Genetics of anorexia nervosa. Curr Psychiatry Rep 2017; 19:84. https://doi.org/10.1007/s11920-017-0842-2CrossRefGoogle ScholarPubMed
Bulik, CM, Tozzi, F, Anderson, C, et al. The relation between eating disorder and components of perfectionism. Am J Psychiatry 2003; 160:366–8. https://doi.org/10.1176/appi.ajp.160.2.366Google Scholar
Duncan, L, Yilmaz, Z, Gaspar, H, et al. Significant locus and metabolic genetic correlations revealed in genome-wide association study of anorexia nervosa. Am J Psychiatry 2017; 174:850–8. https://doi.org/10.1176/appi.ajp.2017.16121402Google Scholar
Frank, G, DeGuzman, M, Shott, M, et al. Association of brain reward learning response with harm avoidance, weight gain, and hypothalamic effective connectivity in adolescent anorexia nervosa. JAMA Psychiatry 2018; 75:1071–80. https://doi.org/10.1001/jamapsychiatry.2018.2151CrossRefGoogle ScholarPubMed
Frank, G, Shott, M, Hagman, J Mittal, V. Alteration in brain structures related to taste reward circuitry in ill and recovered anorexia nervosa and in bulimia nervosa. Am J Psychiatry 2013; 170:1152–60. https://doi.org/10.1176/appi.ajp.2013.12101294CrossRefGoogle ScholarPubMed
Frostad, S, Danielsen, YS, Rekkedal, GÅ, et al. Implementation of enhanced cognitive behaviour therapy (CBT-E) for adults with anorexia nervosa in an outpatient eating-disorder unit at a public hospital. J Eat Disord 2018; 6:12. https://doi.org/10.1186/s40337-018-0198-yGoogle Scholar
Hussain, AA, Hübel, C, Hindborg, M, et al. Increased lipid and lipoprotein concentrations in anorexia nervosa: a systematic review and meta‐analysis. Int J Eat Disord 2019; 52:611–29. https://doi.org/10.1002/eat.23051Google Scholar
Kaye, WH, Wierenga, CE, Bischoff-Grethe, A, et al. Neural insensitivity to the effects of hunger in women remitted from anorexia nervosa. Am J Psychiatry 2020; 17:601–10. https://doi.org/10.1176/appi.ajp.2019.19030261Google Scholar
Lebow, J, Sim, LA, Erwin, PJ, Murad, MH. The effect of atypical antipsychotic medications in individuals with anorexia nervosa: a systematic review and meta-analysis. Int J Eat Disord 2013; 46:332–9. https://doi.org/10.1002/eat.22059Google Scholar
Lock, J. Pocket Guide for the Assessment and Treatment of Eating Disorders. Washington, DC: American Psychiatric Association Publishing, 2019.Google Scholar
Luz Neto, LMD, Vasconcelos, FMN, Silva, JED, et al. Differences in cortisol concentrations in adolescents with eating disorders: a systematic review. J Pediatr (Rio J) 2019; 95:18–26. https://doi.org/10.1016/j.jped.2018.02.007CrossRefGoogle ScholarPubMed
Mahon, PB, Hildebrandt, TB, Burdick, KE. New genetic discoveries in anorexia nervosa: implications for the field. Am J Psychiatry 2017; 174:821–2. https://doi.org/10.1176/appi.ajp.2017.17050574Google Scholar
March, M, Wildes, J. Evidence-based psychological treatment for eating disorders. In: Gabbard, GO, ed. Gabbard’s Treatments of Psychiatric Disorders, 5th edn. Washington, DC: American Psychiatric Publishing, 2014. Available from: https://psychiatryonline.org/doi/full/10.1176/appi.books.9781585625048.gg30Google Scholar
Mehles, P. Anorexia nervosa in adults and adolescents: medical complications and their management. In: Yager, J, Solomon, D, eds. UpToDate, 2019. Available from: https://www.uptodate.com/contents/anorexia-nervosa-in-adults-and-adolescents-medical-complications-and-their-management (accessed March 26, 2021).Google Scholar
Norris, ML, Spettigue, W, Buchholz, A, et al. Olanzapine use for the adjunctive treatment of adolescents with anorexia nervosa. J Child Adolesc Psychopharmacol 2011; 21:213–20. https://doi.org/10.1089/cap.2010.0131Google Scholar
Stahl, S. Olanzapine. In: Stahl’s Essential Psychopharmacology: Prescriber’s Guide, 6th edn. Cambridge, UK: Cambridge University Press, 2017; pp. 527–36.Google Scholar
Walter, K, Bulik, C, Plotnicov, K, et al. The genetics of anorexia nervosa collaborative study: methods and sample description. Int J Eat Disord 2013; 41:289–300. https://doi.org/10.1002/eat.20509Google Scholar
Watson, HJ, Yilmaz, Z, Thornton, LM et al. Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa. Nat Genet 2019; 51:1207–14. https://doi.org/10.1038/s41588-019-0439-2.CrossRefGoogle ScholarPubMed
Yager, J, Devlin, MJ, Halmi, KA, et al. Treatment of Patients with Eating Disorders, 3rd edn. In: American Psychiatric Association Guideline Watch. Available from: https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/eatingdisorders-watch.pdfGoogle Scholar